PL316528A1 - Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders - Google Patents
Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disordersInfo
- Publication number
- PL316528A1 PL316528A1 PL95316528A PL31652895A PL316528A1 PL 316528 A1 PL316528 A1 PL 316528A1 PL 95316528 A PL95316528 A PL 95316528A PL 31652895 A PL31652895 A PL 31652895A PL 316528 A1 PL316528 A1 PL 316528A1
- Authority
- PL
- Poland
- Prior art keywords
- prevetion
- drugs
- treatment
- endothelial disorders
- pharmaceutic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410997A DE4410997A1 (en) | 1994-03-30 | 1994-03-30 | Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL316528A1 true PL316528A1 (en) | 1997-01-20 |
Family
ID=6514213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95316528A PL316528A1 (en) | 1994-03-30 | 1995-03-28 | Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0752858A1 (en) |
JP (1) | JPH09510979A (en) |
CN (1) | CN1150387A (en) |
BG (1) | BG63073B1 (en) |
CA (1) | CA2186783A1 (en) |
CZ (1) | CZ283696A3 (en) |
DE (2) | DE4410997A1 (en) |
EE (1) | EE9600139A (en) |
FI (1) | FI963883A0 (en) |
HU (1) | HU220165B (en) |
IS (1) | IS4365A (en) |
LT (1) | LT4310B (en) |
LV (1) | LV11666B (en) |
MX (1) | MX9604434A (en) |
NO (1) | NO964102D0 (en) |
PL (1) | PL316528A1 (en) |
SI (1) | SI9520047A (en) |
SK (1) | SK121896A3 (en) |
WO (1) | WO1995026725A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423868D0 (en) * | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
DE19604361C2 (en) * | 1996-02-07 | 1999-01-14 | Sanol Arznei Schwarz Gmbh | Use of gas-tight primary packaging for pharmaceutical compositions |
DE19654895C2 (en) * | 1996-02-07 | 2000-07-27 | Sanol Arznei Schwarz Gmbh | Detection method |
DE19726812A1 (en) * | 1997-06-25 | 1999-01-07 | Isis Pharma Gmbh | New nitryl-oxy-methyl derivatives derived from pentaerythritol |
US5958926A (en) * | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
ZA989356B (en) * | 1997-10-16 | 1998-11-16 | Isis Pharma Gmbh | Pharmaceutical preparations |
DE19745622A1 (en) * | 1997-10-16 | 1999-04-22 | Isis Pharma Gmbh | New nitric acid ester derivatives of pentaerythritol |
EP1498124B1 (en) * | 1997-10-17 | 2007-07-04 | Ark Therapeutics Limited | The use of inhibitors of the renin-angiotensin system |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
WO1999067430A2 (en) * | 1998-06-24 | 1999-12-29 | Alpharma-Isis Gmbh & Co. Kg | Analytic substrates and antioxidative agents |
CA2383974A1 (en) | 1999-09-08 | 2001-03-15 | Nitromed Inc. | Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
US7235237B2 (en) | 1999-10-29 | 2007-06-26 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
EP1244455B1 (en) | 1999-10-29 | 2009-07-22 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7708989B2 (en) | 1999-10-29 | 2010-05-04 | Nitromed, Inc. | Methods of treating vascular diseases characterized by nitric oxide insufficiency |
US7537785B2 (en) | 1999-10-29 | 2009-05-26 | Nitromed, Inc. | Composition for treating vascular diseases characterized by nitric oxide insufficiency |
ES2258365B1 (en) * | 2003-10-03 | 2007-12-01 | Lacer, S.A. | DERIVATIVES OF DISULFIDE, SULFIDE, SULFOXIDE AND SULFONE OF CYCLING SUGARS AND THEIR USES. |
US20100144864A1 (en) * | 2007-04-05 | 2010-06-10 | Ironwood Pharmaceuticals, Inc. | Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders |
EA023254B1 (en) * | 2010-05-27 | 2016-05-31 | Мерк Шарп Энд Домэ Корп. | Soluble guanylate cyclase activators |
RU2467748C1 (en) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | 3-(2,2,2-trimethylhydrazinium) propionate derivative - 3-(2,2,2-trimethylhydrazinium) potassium propionate glycinate exhibiting endothelioprotective activity |
JP5360939B2 (en) * | 2011-09-28 | 2013-12-04 | 国立大学法人徳島大学 | A therapeutic agent for arteriosclerosis comprising a nitrosonifedipine derivative as an active ingredient |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR984523A (en) * | 1949-02-10 | 1951-07-06 | Trinitro-triethanolamine phosphate and method of preparation | |
DE1695897C3 (en) * | 1966-07-04 | 1979-02-15 | Takeda Chemical Industries Ltd | N-acyl-sydnonimines, their salts, processes for their preparation and medicaments containing these compounds |
US3886186A (en) * | 1971-04-29 | 1975-05-27 | American Home Prod | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol |
GB1356374A (en) * | 1971-04-29 | 1974-06-12 | American Home Prod | Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol |
DE2532124C3 (en) * | 1975-07-18 | 1979-04-19 | Cassella Ag, 6000 Frankfurt | Process for the production of 4-amino-morpholine |
US4200640A (en) * | 1976-04-02 | 1980-04-29 | Chugai Seiyaku Kabushiki Kaisha | Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use |
DE2623800C3 (en) * | 1976-05-28 | 1978-11-23 | Sanol Schwarz-Monheim Gmbh, 4000 Duesseldorf | Super-saturated aqueous isosorbide dinitrate solution, manufacturing process and use |
US4065488A (en) * | 1977-02-24 | 1977-12-27 | American Home Products Corporation | Process for preparing 1,4:3,6-dianhydro-D-glucitol 2-nitrate |
DE2903927C2 (en) * | 1979-02-02 | 1981-03-12 | Sanol Schwarz-Monheim Gmbh, 4019 Monheim | Process for the selective production of isosorbide-5-nitrate |
DE3028873C2 (en) * | 1980-07-30 | 1983-10-27 | Boehringer Mannheim Gmbh, 6800 Mannheim | Process for the preparation of 1,4 to 3,6-dianhydro-D-glucitol-5-nitrate (isosorbide-5-nitrate) |
DE3102947A1 (en) * | 1981-01-29 | 1982-09-02 | Heinrich Mack Nachf., 7918 Illertissen | METHOD FOR PRODUCING ISOSORBIDE 5-NITRATE |
FR2500835A1 (en) * | 1981-02-27 | 1982-09-03 | Poudres & Explosifs Ste Nale | PROCESS FOR THE SYNTHESIS OF MONONITRATES OF ISOSORBIDE |
DE3117612A1 (en) * | 1981-05-05 | 1982-11-25 | Cassella Ag, 6000 Frankfurt | METHOD FOR PRODUCING ISOSORBIDE 5-NITRATE |
DE3124410A1 (en) * | 1981-06-22 | 1983-01-05 | Heinrich Mack Nachf., 7918 Illertissen | METHOD FOR PRODUCING ISOSORBIDE-2-NITRATE |
JPS5910513A (en) * | 1982-07-12 | 1984-01-20 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation of drug |
DE3325652A1 (en) * | 1983-07-15 | 1985-01-24 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Solid, stable pharmaceutical formulations containing isosorbide 5-mononitrate, and process for the production thereof |
DE3328094A1 (en) * | 1983-08-04 | 1985-02-21 | H. Trommsdorff GmbH & Co, 5110 Alsdorf | Desensitised pharmaceutical formulation of explosive nitric acid esters |
EP0143507B1 (en) * | 1983-11-25 | 1989-09-20 | TOSHIN CHEMICAL CO., Ltd. | A method for the preparation of isosorbide-5-nitrate and sodium isosorbide-5-nitrate hydrate as a precursor thereof |
DD244980A1 (en) * | 1985-12-18 | 1987-04-22 | Isis Chemie Zwickau Veb | PROCESS FOR PREPARING N-MORPHOLINOAMINOACETONITRILE AND ITS HYDROCHLORIDE |
DD293492A5 (en) * | 1987-11-26 | 1991-09-05 | Isis-Chemie Gmbh,De | METHOD FOR THE PRODUCTION OF A GLYCEROLTRINITRATE DRUG FILM WITH SIMILARLY DELAYED DRUG RELEASE |
US5284872A (en) * | 1989-09-12 | 1994-02-08 | Schwarz Pharma Ag | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof |
DE4007705C1 (en) * | 1990-03-10 | 1991-09-26 | G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De | |
DE4038203A1 (en) * | 1990-11-30 | 1992-06-04 | Kali Chemie Pharma Gmbh | Pharmaceutical spray-prepn. for admin. of nitrate(s) - esp. for treatment of cardiovascular, disorders, asthma, migraine and colic |
US5385937A (en) * | 1991-04-10 | 1995-01-31 | Brigham & Women's Hospital | Nitrosation of homocysteine as a method for treating homocysteinemia |
-
1994
- 1994-03-30 DE DE4410997A patent/DE4410997A1/en not_active Withdrawn
-
1995
- 1995-03-28 WO PCT/DE1995/000421 patent/WO1995026725A1/en not_active Application Discontinuation
- 1995-03-28 SK SK1218-96A patent/SK121896A3/en unknown
- 1995-03-28 CN CN95193401A patent/CN1150387A/en active Pending
- 1995-03-28 PL PL95316528A patent/PL316528A1/en unknown
- 1995-03-28 MX MX9604434A patent/MX9604434A/en not_active IP Right Cessation
- 1995-03-28 CZ CZ962836A patent/CZ283696A3/en unknown
- 1995-03-28 SI SI9520047A patent/SI9520047A/en unknown
- 1995-03-28 EE EE9600139A patent/EE9600139A/en unknown
- 1995-03-28 DE DE19580261T patent/DE19580261D2/en not_active Expired - Lifetime
- 1995-03-28 EP EP95914275A patent/EP0752858A1/en not_active Withdrawn
- 1995-03-28 CA CA002186783A patent/CA2186783A1/en not_active Abandoned
- 1995-03-28 HU HU9602671A patent/HU220165B/en not_active IP Right Cessation
- 1995-03-28 JP JP7525343A patent/JPH09510979A/en active Pending
-
1996
- 1996-09-19 LV LVP-96-378A patent/LV11666B/en unknown
- 1996-09-25 IS IS4365A patent/IS4365A/en unknown
- 1996-09-27 NO NO964102A patent/NO964102D0/en not_active Application Discontinuation
- 1996-09-27 FI FI963883A patent/FI963883A0/en unknown
- 1996-10-22 LT LT96-148A patent/LT4310B/en not_active IP Right Cessation
- 1996-10-22 BG BG100930A patent/BG63073B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IS4365A (en) | 1996-09-25 |
HU9602671D0 (en) | 1996-11-28 |
MX9604434A (en) | 1997-12-31 |
SI9520047A (en) | 1997-06-30 |
LT4310B (en) | 1998-03-25 |
LV11666B (en) | 1997-06-20 |
BG100930A (en) | 1997-07-31 |
EP0752858A1 (en) | 1997-01-15 |
AU698359B2 (en) | 1998-10-29 |
CA2186783A1 (en) | 1995-10-12 |
DE19580261D2 (en) | 1997-05-28 |
NO964102L (en) | 1996-09-27 |
JPH09510979A (en) | 1997-11-04 |
CZ283696A3 (en) | 1998-03-18 |
HU220165B (en) | 2001-11-28 |
FI963883A (en) | 1996-09-27 |
DE4410997A1 (en) | 1995-10-26 |
BG63073B1 (en) | 2001-03-30 |
LV11666A (en) | 1997-02-20 |
AU2134595A (en) | 1995-10-23 |
WO1995026725A1 (en) | 1995-10-12 |
HUT76676A (en) | 1997-10-28 |
EE9600139A (en) | 1997-04-15 |
NO964102D0 (en) | 1996-09-27 |
LT96148A (en) | 1997-12-29 |
SK121896A3 (en) | 1998-10-07 |
FI963883A0 (en) | 1996-09-27 |
CN1150387A (en) | 1997-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL316528A1 (en) | Pharmaceutic compositions and drugs for prevetion and treatment of endothelial disorders | |
IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
HUP0100815A3 (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
HUP0001442A3 (en) | Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders | |
IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
HUP9601566A2 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
EP0707446A4 (en) | Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology | |
HUP9601698A3 (en) | Pharmaceutical composition of adiabetical activity | |
HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
HU9502918D0 (en) | Pharmaceutical composition of antihypertriglyceridemic activity | |
GB2311940B (en) | Pharmaceutical compositions for the treatment of rhinitis | |
HUP0200287A3 (en) | Pharmaceutical compositions for the treatment of neurological or neuropsychiatric disorders | |
AU3151097A (en) | Pharmaceutical for treating of neurological and neuropsychiatric disorders | |
IL119225A (en) | Pharmaceutical compositions for the treatment of asthma in mammals | |
HU0500865D0 (en) | Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock | |
IL115982A (en) | Cyclolignan derivatives and pharmaceutical compositions containing them | |
EP0687687A3 (en) | Pharmaceutical compositions for prevention and treatment of blood coagulation disorders | |
IL120005A0 (en) | Pharmaceutical compositions for the treatment of the eye | |
EP0564216A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina | |
IT1277117B1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | |
IL116012A0 (en) | 6-methoxy-1h-benzotriazole-5 carboxamide derivatives their preparation and pharmaceutical compositions containing them |